Concord Biotech Share Price Live blog for 12 Sep 2023
Concord Biotech stock price went down today, 12 Sep 2023, by -1.77 %. The stock closed at 1013.85 per share. The stock is currently trading at 995.9 per share. Investors should monitor Concord Biotech stock price closely in the coming days and weeks to see how it reacts to the news.
Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to regulation 47 of SEBI (LODR) regulations, 2015, Please find enclosed herewith extracts of the consolidated unaudited financial results for the quarter ended on June 30, 2023 as published in the Financial Express all editions and Gujarati language in Ahmedabad editions. Further, in terms of regulations 46, of SEBI LODR, the said financials results are also uploaded on the website of the company (www.concordbiotech.com) Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, and further to our intimation dated September 01, 2023 to the exchange regarding Earning call in respect of the Unaudited Financial Results of the company for the Quarter ended June 30, 2023, we wish to inform that the said Earning Call was held today at 4:00 PM (IST). The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :- https://www.concordbiotech.com/public/assets/pdf/Q1FY24-Earnings-call.mpeg Kindly take the above on records. Concord Biotech Share Price Live blog for 07 Sep 2023
Concord Biotech stock price went up today, 07 Sep 2023, by 1.93 %. The stock closed at 988.9 per share. The stock is currently trading at 1008 per share. Investors should monitor Concord Biotech stock price closely in the coming days and weeks to see how it reacts to the news. Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, a results presentation to analyst/investor for the period ended June 30, 2023 is enclosed. Kindly take the above on records. Concord Biotech Ltd - 543960 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E Wednesday, September 06, 2023- Unaudited Financial Results For The Quarter Ended June 30, 2023
With reference to the intimation of Board meeting submitted on August 29, 2023, we would like to inform you that the Board of Directors of the Company, at its meeting held today i.e. Wednesday, September 06, 2023, has inter-alia, approved Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2023. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2023, along with the Limited Review Report of the Statutory auditors. The Board Meeting commenced at 2:30 PM and concluded at 3:30 PM. This is for your information and records. Concord Biotech Share Price Live blog for 06 Sep 2023
Concord Biotech stock price went up today, 06 Sep 2023, by 2.1 %. The stock closed at 969.6 per share. The stock is currently trading at 990 per share. Investors should monitor Concord Biotech stock price closely in the coming days and weeks to see how it reacts to the news. Concord Biotech Share Price Live blog for 05 Sep 2023
Concord Biotech stock price went down today, 05 Sep 2023, by -0.33 %. The stock closed at 968.15 per share. The stock is currently trading at 965 per share. Investors should monitor Concord Biotech stock price closely in the coming days and weeks to see how it reacts to the news. Concord Biotech Share Price Live blog for 04 Sep 2023
Concord Biotech stock price went down today, 04 Sep 2023, by -0.23 %. The stock closed at 973.85 per share. The stock is currently trading at 971.6 per share. Investors should monitor Concord Biotech stock price closely in the coming days and weeks to see how it reacts to the news. Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We wish to inform you that the Company has arranged Earnings Call with Investor/Analyst (Participants) to discuss the unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter ended 30 June 2023, scheduled on Thursday, 7th September 2023 at 4:00 P.M. IST. The Earnings Call invite is enclosed for your records. This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, as amended. Kindly take the same into your records and oblige.